DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $218,624 | -40.2% | 24,400 | -24.9% | 0.00% | 0.0% |
Q2 2023 | $365,625 | -80.0% | 32,500 | -79.6% | 0.00% | -80.0% |
Q1 2023 | $1,831,530 | +1.7% | 158,987 | +2.3% | 0.01% | -16.7% |
Q4 2022 | $1,800,495 | +733.6% | 155,349 | +812.5% | 0.01% | +500.0% |
Q3 2022 | $216,000 | -16.3% | 17,024 | -36.3% | 0.00% | 0.0% |
Q1 2022 | $258,000 | -83.0% | 26,722 | -79.1% | 0.00% | -66.7% |
Q4 2021 | $1,519,000 | -17.4% | 127,729 | +12.8% | 0.00% | -25.0% |
Q3 2021 | $1,838,000 | +355.0% | 113,204 | +335.4% | 0.00% | +300.0% |
Q1 2021 | $404,000 | – | 26,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |